Snip.it has been acquired by Yahoo! Snip.it is a social news start-up that allows news consumers to clip, organize and share articles.
1 min read · 24 January 2013
Allergan and MAP Pharmaceuticals have entered into a definitive merger agreement whereby Allergan will acquire 100 percent of the shares of MAP Pharmaceuticals for a price of $25.00 per share. Latham & Watkins advised MAP in the transaction.
9 min read · 24 January 2013
Commonfund has appointed Bradford K. Gallagher as chairman, board of trustees. Gallagher succeeds Laurance R. Hoagland, who has retired from its board after serving a 12-year term. Commonfund has also announced the retirement of Charles J. Pippin from its board, again after serving a term of 12 years.
3 min read · 24 January 2013
Global private equity asset management firm Hamilton Lane is expanding its Europe-based presence with the addition of Paul Waller to the newly-created role of partner in its London office. Waller recently retired as a managing partner from 3i after 35 years and will focus primarily on client development and overall firm marketing initiatives.
2 min read · 24 January 2013
Gresham Private Equity has exited 7city Learning through the sale of the business to Fitch Group. The sale represents a strong realisation for Gresham.
3 min read · 24 January 2013
Darwin Private Equity is to sell its portfolio company Plum Baby Limited to Plum Organics, in return for shares in Plum Organics. The merged group will have over 150 products sold in over 13,000 stores internationally with retail sales in excess of $120 million.
4 min read · 24 January 2013
This morning First Read brings you the latest on a Sequoia partner departure, those myths surrounding the Euro venture industry, an update on Indian private equity and why the million dollar club is a preferred investment stage for many VCs.
1 min read · 24 January 2013
Progenics Pharmaceuticals has acquired Molecular Insight Pharmaceuticals, a clinical-stage specialty pharmaceutical company focused on critical unmet diagnostic and therapeutic needs of the prostate cancer patient. O’Melveny & Myers represented Progenics Pharmaceuticals.
5 min read · 23 January 2013
DH Capital has appointed Sean Charnock as a managing director. Prior to DH Capital, Charnock was co-founder and SVP of business development and alliances at SoftLayer Technologies.
2 min read · 23 January 2013
Financing platform Prosper has appointed Stephan Vermut as chief executive officer and member of the board of directors. Vermut succeeds Dawn Lepore, who has served as interim CEO since March 2012. Prosper is backed by Sequoia Capital.
4 min read · 23 January 2013
